Literature DB >> 12866374

Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases.

Peiguo G Chu1, Daniel A Arber, Lawrence M Weiss.   

Abstract

We studied the expression of CD2, CD3, CD4, CD5, CD7, CD8, CD56, and CD138 in 447 cases of common human neoplasms with epithelioid features. CD2, CD3, CD4, and CD8 antigens were detected in none of 447 cases of nonhematopoietic tumors. CD5 and CD7 antigens were expressed in 12.3% and 19.5% of cases of nonhematopoietic tumors, respectively. Their expression was found primarily in adenocarcinomas from the gastrointestinal tract, breast, and female reproductive organs. The high expression of CD5 and CD7 antigen in pancreatic ductal carcinoma and cholangiocarcinoma and high expression of CD7 in epithelioid sarcoma may have diagnostic value. One quarter of cases were positive for CD56. Overexpression of CD56 antigen was detected mainly in neuroendocrine tumors or adenocarcinomas with neuroendocrine differentiation. Its consistent overexpression in adrenal cortical and thyroid tumors may have diagnostic usefulness. Virtually all tumor types studied were CD138+ with a variable positivity rate. The negative staining of CD138 in malignant mesothelioma may be useful for separating mesothelioma from metastatic adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12866374     DOI: 10.1309/48KC-17WA-U69B-TBXQ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

1.  The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.

Authors:  Jody E Hooper; Terry K Morgan; Markus Grompe; Brett C Sheppard; Megan L Troxell; Christopher L Corless; Philip R Streeter
Journal:  Hum Pathol       Date:  2012-03-09       Impact factor: 3.466

Review 2.  [The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas].

Authors:  F Länger; R von Wasielewski; H H Kreipe
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

3.  CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions.

Authors:  I Gütgemann; S Haas; J P Berg; H Zhou; R Büttner; H-P Fischer
Journal:  Virchows Arch       Date:  2006-01-13       Impact factor: 4.064

Review 4.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

5.  Renal neuroendocrine tumors.

Authors:  Brian R Lane; George Jour; Ming Zhou
Journal:  Indian J Urol       Date:  2009-04

6.  Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2.

Authors:  Bálint Péterfia; Tibor Füle; Kornélia Baghy; Krisztina Szabadkai; Alexandra Fullár; Katalin Dobos; Fang Zong; Katalin Dobra; Péter Hollósi; András Jeney; Sándor Paku; Ilona Kovalszky
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

7.  Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies.

Authors:  Filip Mundt; Ghazal Heidari-Hamedani; Gustav Nilsonne; Muzaffer Metintas; Anders Hjerpe; Katalin Dobra
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

8.  Rare Breast Carcinoma with Paradoxical Plasma Cell Immunoprofile: A Case Report.

Authors:  Eugen Sebastian Grădinaru; Mihai-Ciprian Stoicea; Liliana Mocanu; Iulian Antoniac; Daniela Gheorghiță; Alina Gabriela Mihaela Grigore
Journal:  Medicina (Kaunas)       Date:  2020-02-05       Impact factor: 2.430

Review 9.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

10.  High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer.

Authors:  Joe Yeong; Jeffrey Chun Tatt Lim; Bernett Lee; Huihua Li; Noel Chia; Clara Chong Hui Ong; Weng Kit Lye; Thomas Choudary Putti; Rebecca Dent; Elaine Lim; Aye Aye Thike; Puay Hoon Tan; Jabed Iqbal
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.